California State Teachers Retirement System (CalSTRS)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
142,561
+43,257
+44% +$540K ﹤0.01% 1660
2025
Q4
$1.28M Sell
99,304
-4,892
-5% -$62.8K ﹤0.01% 1675
2025
Q3
$1.35M Buy
104,196
+9,241
+10% +$123K ﹤0.01% 1638
2025
Q2
$1.69M Buy
94,955
+812
+0.9% +$14.2K ﹤0.01% 1454
2025
Q1
$1.68M Sell
94,143
-2,246
-2% -$51K ﹤0.01% 1427
2024
Q4
$2.87M Sell
96,389
-635
-0.7% -$13.4K ﹤0.01% 1184
2024
Q3
$1.52M Sell
97,024
-2,582
-3% -$46.8K ﹤0.01% 1553
2024
Q2
$1.71M Sell
99,606
-2,352
-2% -$41.4K ﹤0.01% 1472
2024
Q1
$1.59M Sell
101,958
-5,686
-5% -$83.6K ﹤0.01% 1551
2023
Q4
$1.61M Sell
107,644
-4,935
-4% -$66K ﹤0.01% 1575
2023
Q3
$1.82M Sell
112,579
-44,719
-28% -$1.29M ﹤0.01% 1446
2023
Q2
$6.53M Sell
157,298
-4,024
-2% -$250K 0.01% 818
2023
Q1
$9.7M Sell
161,322
-1,537
-0.9% -$123K 0.01% 656
2022
Q4
$11.9M Buy
162,859
+2,877
+2% +$216K 0.02% 599
2022
Q3
$12.2M Sell
159,982
-1,751
-1% -$137K 0.02% 580
2022
Q2
$11.2M Buy
161,733
+1,048
+0.7% +$78.9K 0.02% 611
2022
Q1
$13.3M Sell
160,685
-10,176
-6% -$750K 0.02% 620
2021
Q4
$12.8M Sell
170,861
-773
-0.5% -$77.6K 0.02% 676
2021
Q3
$19.9M Sell
171,634
-12,657
-7% -$1.91M 0.03% 549
2021
Q2
$40.9M Sell
184,291
-6,035
-3% -$1.17M 0.05% 339
2021
Q1
$25.2M Buy
190,326
+140
+0.1% +$22.1K 0.03% 475
2020
Q4
$32.9M Buy
190,186
+14,828
+8% +$2.03M 0.05% 356
2020
Q3
$19.5M Buy
175,358
+4,233
+2% +$338K 0.03% 467
2020
Q2
$10.1M Buy
171,125
+39,086
+30% +$2.57M 0.02% 657
2020
Q1
$8.89M Sell
132,039
-654
-0.5% -$51.7K 0.02% 594
2019
Q4
$11.2M Sell
132,693
-2,680
-2% -$216K 0.02% 645
2019
Q3
$10.1M Buy
135,373
+4,900
+4% +$392K 0.02% 656
2019
Q2
$8.25M Buy
130,473
+17,791
+16% +$901K 0.02% 741
2019
Q1
$5.43M Sell
112,682
-2,585
-2% -$124K 0.01% 925
2018
Q4
$3.86M Buy
115,267
+2,677
+2% +$97.9K 0.01% 1061
2018
Q3
$5.9M Buy
112,590
+2,633
+2% +$105K 0.01% 918
2018
Q2
$3.44M Buy
109,957
+20,784
+23% +$578K 0.01% 1248
2018
Q1
$1.94M Sell
89,173
-1,873
-2% -$40.3K ﹤0.01% 1544
2017
Q4
$1.84M Sell
91,046
-1,423
-2% -$27.4K ﹤0.01% 1626
2017
Q3
$1.84M Sell
92,469
-9,840
-10% -$193K ﹤0.01% 1630
2017
Q2
$1.77M Buy
102,309
+2,600
+3% +$33.6K ﹤0.01% 1675
2017
Q1
$808K Sell
99,709
-4,500
-4% -$32.5K ﹤0.01% 2203
2016
Q4
$818K Sell
104,209
-2,900
-3% -$23.3K ﹤0.01% 2234
2016
Q3
$915K Buy
107,109
+900
+0.8% +$8.21K ﹤0.01% 2138
2016
Q2
$1.24M Buy
106,209
+88,030
+484% +$1.1M ﹤0.01% 1909
2016
Q1
$263K Buy
18,179
+2,529
+16% +$36.3K ﹤0.01% 2721
2015
Q4
$350K Buy
+15,650
New +$374K ﹤0.01% 2633

Other funds holding NVCR

California State Teachers Retirement System (CalSTRS)'s NVCR Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its NovoCure (NVCR) stake by 44% in Q1 2026, buying an estimated $540K and bringing the position to 142,561 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

California State Teachers Retirement System (CalSTRS) first reported a position in NVCR in Q4 2015 and has held it in 42 quarters since. The position peaked at $40.9M in Q2 2021. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 142,561 shares of NovoCure worth $1.55M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 43,257 NovoCure shares in Q1 2026, an estimated $540K.
  • NovoCure made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1660 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in NovoCure in Q4 2015 and has held it in 42 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s NovoCure position peaked at $40.9M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.